First trimester screening of serum advanced glycation end products levels of pregnant women who have risk factors for gestational diabetes and their obstetric outcomes: a preliminary case-control study
- 2 June 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (7) , 3048-3054
Abstract
Advanced glycation end-products (AGE) are complex compounds formed by nonenzymatic glycosylation of proteins, nucleic acids, and lipids with glucose in the blood. We aimed to investigate whether there was a difference in first-trimester serum AGE levels of pregnant women with and without risk factors for gestational diabetes mellitus (GDM) and their obstetric outcomes. There were 44 women in study group who have risk factors for GDM and 44 as controls. Demographic features, serum AGE levels, adverse perinatal and neonatal outcomes were compared between groups. Five patients (11.4%) in the study group and one patient (2.3%) in the control group were diagnosed as GDM (p = .2). The serum AGE values were not statistically different between the study and control groups. There were no statistical differences between groups in terms of adverse perinatal and neonatal outcomes. However, in the group with adverse perinatal outcome (n = 25), AGE values were higher than the control group. The results of our preliminary study suggested that high-risk women for GDM did not have increased serum levels of AGE in the first trimester. Nevertheless, a high first-trimester serum AGE level was found to be associated with adverse perinatal outcomes.Keywords
This publication has 39 references indexed in Scilit:
- Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic reviewEuropean Journal of Clinical Nutrition, 2013
- Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended CriteriaDiabetes Care, 2012
- The relationship of serum AGE levels in diabetic mothers with adverse fetal outcomeJournal of Perinatology, 2009
- ORIGINAL ARTICLE: Glycation Endproducts, Soluble Receptor for Advanced Glycation Endproducts and Cytokines in Diabetic and Non‐diabetic PregnanciesAmerican Journal of Reproductive Immunology, 2009
- The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammationAmerican Journal of Obstetrics and Gynecology, 2007
- Placental adaptive responses and fetal programmingThe Journal of Physiology, 2006
- Accumulation of Advanced Glycation End Products in Women with Preeclampsia: Possible Involvement of Placental Oxidative and Nitrative StressPlacenta, 2006
- Advanced glycation end products and the kidneyAmerican Journal of Physiology-Renal Physiology, 2005
- Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy OutcomesNew England Journal of Medicine, 2005
- Protein Glycation, Diabetes, and AgingRecent Progress in Hormone Research, 2001